#468: SaMD Issues, Defects & Detection | Shawnnah Monterrey

Global Medical Device Podcast · 10 Aug 2026 · 44m · Episode 468

What this episode covers

Shawnnah Monterrey, founder of Beanstalk Ventures and an FDA-accredited third-party reviewer, discusses post-market quality issues in medical devices, drawing on her experience at ZEISS and Illumina. She explains how inadequate upstream characterization, such as neglecting shipping stresses or subsystem-level DFMEAs, leads to costly 'dead on arrival' failures and field complaints. The conversation highlights the importance of robust unit testing, clear design documentation, and structural post-market surveillance to prevent catastrophic recalls, using a Class 1 ventilator case study to illustrate software-hardware interaction failures. Monterrey also addresses the challenges of integrating AI-generated code into maintainable systems and the critical need for open communication loops between R&D, manufacturing, and post-market teams to feed field intelligence back into product design.

Other shows on the same ground, closest first.

  • Let's Combinate · 17m

    217 - 5 Fixable Problems Holding Back Drug–Device Programs

    Subhi Saadeh, founder of Let’s Combinate BioWorks, outlines five critical quality issues in drug-device combination products, drawing on his experience at Pfizer, Gilead, and Baxter. He addresses documentation misalignment in design transfer, late manufacturing input, arbitrary sampling plans, unclear method transfer ownership, and supplier qualification gaps. Saadeh proposes solutions such as integrating pharma change controls with device design plans, embedding DFM/DFA reviews, and adopting PPAP frameworks for component qualification. The episode emphasizes harmonizing drug and device development processes to ensure scalable, compliant, and patient-ready solutions.

  • Let's Combinate · 1h 12m

    024 - "Operating Under Constraints "with Naveen Agarwal

    Naveen Agarwal, a PhD polymer scientist and quality management consultant at Creative Analytics Solutions, discusses operating under constraints, drawing parallels between his 1,500-mile running challenge and risk management in medical devices. He explains the distinction between post-market vigilance and surveillance, advocating for a customer-experience-focused approach to quality improvement that goes beyond regulatory compliance. Agarwal introduces the SNIP framework (Strength, New, Importance, Preventable) for data-based decision-making in post-market surveillance and argues that safety performance should drive innovation and reimbursement rather than just meeting baseline safety standards.

  • Let's Combinate · 45m

    123 - Uncovering HUGE Quality Issues, Inspection Readiness in 2024, Data Integrity, AlCOA+/PIC/S and Critical Thinking in Quality Management with Peter Baker

    Peter Baker, President of Live Oak Quality Assurance and former FDA Drug Investigator, discusses his career uncovering data integrity breaches in overseas manufacturing facilities. He explains that 99% of data integrity issues stem from poor process design and 'right environment' failures rather than human error, urging companies to shift from compliance-focused checklists to quality-driven critical thinking. Baker highlights specific field failures, such as the manipulation of product quality by blending failed batches with passing ones, and emphasizes the importance of honest reporting of unknown discrepancies to ensure patient safety.

  • The Amp Hour · 1h 20m

    Photon Rich, Cash Poor

    Dave Jones and Chris Gammell discuss a Keysight U1272A multimeter that suffers from severe susceptibility to conducted and radiated EM fields, a flaw inherent to its design that bypassed standard compliance testing. They also examine the Allwinner R8 processor and the new Chip Pro module, noting how the latter's System-on-Module design with integrated DDR3 makes previously inaccessible consumer chips viable for small-batch production. Finally, they critique the Wi-Fi kettle's usability failures and Solar Roadways' non-functional public installation, attributing these to marketing-driven product decisions rather than engineering value.

  • The Builder Circle · 1h 01m

    S2 E8: Quality Engineering and Strategy for Hardware with Matt Lipsitz

    Matt Lipsitz, Head of Quality at Formlabs, explains that quality is a culture of managing risk to meet customer expectations, starting with Failure Modes and Effects Analysis (FMEA) in the design phase. He details how startups can build a low-touch quality infrastructure by defining clear specifications, validating them through testing, and implementing proactive control points in the supply chain to catch defects before they reach the field. Lipsitz emphasizes that successful quality requires deep knowledge transfer, often involving on-site supplier partnerships, and treating every downstream partner as a customer to ensure alignment on critical-to-quality metrics.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.